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Recently, two patients with the Dowling-Meara subtype of 
epidermolysis bullosa simplex (EBS-DM) were reported 
with different mutations in codon 125 of the keratin 14 gene. 
To determine whether these are common mutations, we 
screened ten EBS-DM patients and their fami lies using single 
nucleotide primer extension. Four of ten unrelated EBS-DM 
patients had a G~A substitution at base pair 434 of codon 
125, whereas one case out of ten had a C~T substitution at 
position 433 of th e .same codon. The G434A alt.eration c~s~g­
regated wi th the dIsorder 11l two multigeneratlOnal falTIlltes; 
no recombination events were detected. In these two fami-
lies, linkage ana lysis provided significant evidence in favor of 
T he term epidermolysis bullosa refe. rs to a heteroge-neous group of dIsorders charac terized primarily by skin frag ility and blister formation [1,2]. Three gen-era l ca tegories of these disorders ar e recognized: sim-p lex, where cell lysis occurs in the epidermis within or 
above th e basa l keratinocyte; junctional, where the separation 
occurs within the dermal-epidermal junction; and dystrophic, in 
wh ich the plane of cleavage is below the basement m embrane in th e 
derm is. Epidermolysis bullosa simplex (EBS), the mildest of these 
disorders, is commonly inherited in an autosomal dominant fashion, 
altho ug h a pedigree w ith possible autosomal recessive inheritance 
has been reported [2,3]. Differences in clinical presentation and 
ultrast ructural findings serve to divide the EBS disorders into several 
subtypes ([2] for review) including the herpetiformis, or Dowlin g-
M eara (EBS-DM) subtype, w hich is distinguished by the presence 
of distinctive cl umps of keratin fil am ents in the basal cells [4,5]. 
Stud ies of basal keratinocyte ultrastructure of EBS-D M patients [6] 
and of keratin 14 deletions in transgenic mice [7] have implicated 
the basal cell -specific keratins, keratin 5 and keratin 14, as candidate 
genes for EBS-D M . Recently, EBS-DM -affected individuals have 
been identified w ith mutatio ns in o ne or the other of these keratins 
[8,9]. Two unrelated sporadic cases ofEBS-DM were reported that 
ca rri ed twO different mutations in codo n 125 o f keratin 14, a C to T 
transit ion at the first positio n of codon 125 and a G to A transition at 
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linkage between G434A and the EBS-DM phenotype, with a 
LOD score of3.29 at a recombination rate ofO%. Codon 125 
substitutions identified in three unrelated sporadic EBS-OM 
patients were not found in their clinically unaffected parents. 
Together, these data provide compellin g genetic evidence 
that the codon 125 substitutions are causal for EBS-DM. The 
hi gh frequency of mutation at this site in individuals with 
EBS-DM now makes DNA-based diagnosis of this disorder 
feasible. Key words: Genodermatosis, blisters, intermediate 
filaments, epidermolysis bullosa herpetiformis. ] !l11lesl Der-
malo/101:240 -243, 1993 
the second position [9]. These trans itions resulted in Arg -+ Cys and 
Arg -+ His substitutions, both of which disrupted keratin fil ament 
assembly , su ggestin g that these DNA sequence alterations were 
responsible for the EBS-DM phenotype in these individuals [9] . In 
this report we demonstrate that codo n 125 of keratin 14 is fre-
quently mutated in EBS-DM, provide stro ng genetic evidence that 
mutations in codon 125 of keratin 14 are causal for the disorder, and 
discuss the implications of oll r results for prenatal d iagnosis of this 
diso rder. 
MATERIALS AND METHODS 
EBS-DM Families Families wi th EBS-DM were ascerta ined th rough the 
National Epidermolysis Bullosa Registry, advertisement by the Dystrophic 
Epidermolysis Bullosa Research Association, and by referral directly to one 
of the authors (VPS) . The diagnosis of EBS-DM was made on the basis of 
typical clinical fea tures, ultrastructural findings of a spli t wi thin the epider-
mis, and the diagnostic clumping of basal keratin filaments in at least one 
fa mily member and, where more than one family member was affected, 
evidence for vertical transmission. T en pedigrees, six of sporadic cases and 
four of familial , with a total of 22 affected individuals, were identified (Fig 
1). The fami lies were of varied ethnic origins; nine were from the United 
States and one was from Canada; none of the families was found to be related 
to any other. Peripheral blood leukocytes, obtained from affected individuals 
and as many first-degree re lati ves as possible, were immorta lized by trans-
formation with Epstein-Barr vi rus [1 0]. To confirm paternity and pedigree 
structure, the segregation of alleles for five highl y polymorphic loci were 
ana lyzed for each fa mily; results were consistent with reported information 
(data not shown) . 
Single Nucleotide Primer Extension (SNuPE) An exon 1 fragment of 
keratin 14 (from bp 274 to 626; [11]) was amplified by the polymerase chain 
reaction (PCR) with primer 5 and an intron 1-specific primer [9] for 35 
cycles each for 1 min at 94 ·C, 1 min at 70·C, and 0.5 min at 72 ·C. Direct 
sequencing of this product verified that th e amplified product was the au-
thentic exon 1 fragment (data not shown). Amplified product (100 Jil) was 
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Figure 1. EllS:DM families. Pe?igrees of the 10 families are shown; the 
numbered individuals 111 each fami ly were ava ilable for study. Male (sq llares), 
fe male (circles), sex not determined for this study (triallgles) , affec ted with 
EBS-DM (so/id s)'lIIbo/s), unaffected (opell s)'/IIbo/s), deceased (slashed S}'I11 ~ 
boIs). 
electrophoresed and purified from an agarose gel slice, resuspended in 40 Jll 
water, and divided into two tubes for SNuPE assays [1 2]. Each 50-tll assay, 
containing 20 JlI of the exon 1 amplified product, 100 ng of the primer 
K14-458 (Fig 2), 5 pi of 10 X PCR buffer (Perkin Elmer, 15 mM MgClz), 2 
Units T aq polymerase, and 1 JlI of the appropriate alpha-32P-dNTP (3000 
Ci/mmole, 10 tlCi/ pi), was subjected to one cycle of 2 min at 94°C, 2 min 
at 65 °C, and 2 min at 72 °C. The extension products were electrophoresed 
through a 12% polyacrylamide gel that was dried and exposed to Kodak 
X-OMAT AR film. For the SNuPE assays, where each of the four l1uclco-
tides were tested (Fig 2B) , we began with 200 JlI of amplified exon 1 product 
and 3 pmole of unlabeled dCTP was added to each assay to permit extension 
of the K 14-458 primer past the G nucleotide at position 434 (Fig 2B). The 
downstream primer K14-458 was chosen after an upstream primer gave 
incol1sistent results, presumably due to primer mismatch at polymorphic 
nucleotide 429 in some individuals (Fig 2). Negative controls where tem-
plate DNA was omitted from either the exon 1 amplification reaction or the 
SNuPE assays never gave product. 
Linkage Analyses Pairwise linkage analyses were performed with the 
computer program LIPED [13] under a model of full y penetrant autosomal 
dominant inheritance and a gene frequency of 0.005 for EllS-DM. L111kage 
analyses were performed with two differenr estimates of the G434A all ele, 
0.036 and 0.5. The lower frequency was chosen as the upper 95% confidence 
bound, given th at the G434A allele did not occur upon direct sequencing of 
80 sample chromosomes from control individuals (this study and [9]). The 
higher frequency of 0.5 was chosen to determine the sensitivity of the 
analysis to the assumed gene frequency because recent resu lts have shown 
that LOD scores can be inflated by underestimating marker allele frequen-
cies [14] . 
RESULTS 
Five of ten unrelated EBS-OM patients and their affected relatives 
carried a nucl eotide substitution at codon 125 of the keratin 14 
gene. Four of the five substitutions were G --> A transi tions at base-
pair 434 (G434A), th e second position of codon 125, ide ntified in 
affec ted individuals EB2-1, EB6-1, EB20-6, and EB27-3 (Fig 1). An 
example of the SNuPE assay used to detect these transitions is 
shown in Fig 2A, where all members of family EB6 were assayed. 
A ll clinica ll y unaffected individuals have a 25-bp product due to 
primer extension of th e normal allele in the prese nce o f alpha_ 32P_ 
dCTP (lanes labeled C), In addition to this product, all affec ted 
individuals also have a 25-bp product due to primer extension of th e 
m utant allel e in th e presence of rad iolabeled TTP (lanes labeled T) . 
These data demonstrated that in family EB6 all affected individuals 
were h eterozygous for th e G434A substitution and that this alter-
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atio n cosegregated with the EBS-OM phenotype. Similar SNuPE 
assays demonstrated cosegregation of the G434A substitution and 
the EBS-OM phenotype in famil y EB2. Linkage analysis between 
the G434A subst itu tion and EBS- OM in these two families gave a 
LOO score of 3.29 at a recombination frequency of 0% (calculated 
at a G434A frequency = 0.036, see Materials Qlld Methods). These 
data provided statistically significant ev idence that G434A is linked 
to EBS-DM. The sporadic patients EB20-6 and EB27-3 w ere also 
heterozygous for G434A (data not shown), and this alteration was 
not found in either of their clinically unaffected parents. 
One patient, EB 11-3, the o nl y affected individual in this fami ly 
(Fig 1), had a C --> T substitution mutation at bp 433 (C433T), the 
first position of codon 125. Figure 2B compares the results of the 
SNuPE assay for position 433 between a control individual and 
EB 11-3. In the presence of radio labe led dGTP, both indiv iduals 
produced 26 and 27 basepair fragm ents resu lting from extension of 
A 
B 
Family EB6, individual # 
1112 3456 
CTCTICTICTICTICTI M 
1 7 1 8 1 9 1 1 01 111 
MCTCTCTCTCTM 
---- - ---
*his 
J 22 Leu Asn Asp ~~g Leu AlA Scr Tyr Leu Asp Lys Va l Arg 
424 e r e AAT/C GAe CGC CTG GCC TCC TAC CTG GAC AAG GTG CGT 3' 
lG GAC CGG AGG ATG GAC CTG nc CA l 5' 
GGAA CCTT 
~?,=" ::: 
2.1- - -
123 45 678 
li<cys 
J22 Leu ASH A sp !:.rs Leu Ala Scr Tyr Leu Asp Lys Val Arg 
424 CTC AAT/C GAC CGC erG GCC TCC TAC CTG GAC AAG GTG CGT 3' 
lG GAC CGG AGG ATG GAC CTG n c CA 1 5' 
Figure 2, SNuPE assays for codon 125 mutations. (A) Assay for the G -> A 
substitution at position 434. The sequence of a portion of the exon 1 PCR 
amplified product surrounding codon 125 is shown with the mutation and 
corresponding amino acid substitution indicated by asterisks. The si lent poly-
morpillsm at pOSitIOn 429 IS IIldlcated [9]. Upon annealin g to either the 
normal or mutant allele, the 3' end of primer 14-458 (boxed) can be extended 
in the presence of the appropriate radiolabeled nucleotide. The 3utoradio-
graphs show the products ofSNuPE assays for each of 11 members of Family 
EB6; for each person the primer was assayed for extension in the presence of 
either radiolabeled dCTP (lalles //l arked C) or TTP (lall es //larked T). Lall f M, 
25-bp size marker. The products extended with TTP always electrophor-
esed sli ghtly slower than predicted for a 25-bp product but not sufficiently 
slow to comigrate with a 26-bp marker fragment (data not shown); this sh ift 
was presumably due to a minor difference in secondary structure. (B) Assay . 
for the C -> T substitution at position 433. As described above, the mutation 
and corresponding amino acid substitution at codon 125 arc marked with an 
asterisk. Extension of primer K14-458 to the mutational site at basepair 433 
required the presence of unlabeled dCTP to permit extension th rough the G 
residue at position 434. Exon 1 PCR amplified product for EB 11-3 and the 
control individual was divided into four reactions, each annealed to primer 
K14-458 and extended by Taq polymerase in the presence of only one 
specific alpha-32P-dNTP (lalles labeled C,A,C, T). The gel compares the re-
su lts for affected individual EB 11 -3 (lalles 2,4,6,8) and an unrelated , unaf-
fected control individual (lalles 1,3,5,7) ; sizes of products in basepairs were 
determined frOI11 size markers (not shown). 
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the normal allele to either of the G residues at positions 433 or 432 
(lanes 1,2). However, only individual EB1 1-3 gave a 26-bp exten-
sion product in the presence of radio labe led dATP, demonstrating 
that he ca rri es the C-433 -+ T substitution (lanes 3,4). As expected 
for both the control and the proband, SNuPE reactions in the pres-
ence of dCTP resulted in a 25-basepair product due to incorporation 
at pos ition 434 (l anes 5,6), whereas SNuPE in the presence of radio-
labeled TTP produced no product (lanes 7,8). These data demon-
strated that individual EB 11-3 was heterozygous at position 433; 
the normal all ele had a C residue and the mutant all ele a T. The 
C433T alteration was not found in either of the clinica lly unaf-
fected parents of EB 11 -3 (data not shown) . 
T he five EBS-DM cases that did not have mutations at codon 125 
of keratin 14 were examined for a mutation in keratin 5 reported 
previously in one EBS-DM family [8]. U sing allele-specific hybrid-
ization, we found that none of these cases carries the A -+ G substi-
tution in th e helix te rmination peptide of keratin 5 (data not 
shown). 
DISCUSSION 
We have shown that affected individuals in five of ten unrelated 
EBS-DM fami l ies carry nucleotide substitutions in codon 125 of the 
keratin 14 gene. A G -+ A transition at basepair 434 was observed in 
four cases and a single additional case had a C -+ T transition at bp 
433 (Fig 2). Our study of EBS-DM families has provided severa l 
lines of genetic ev idence that these nucleotide substitutions repre-
sent mutations responsible for the EBS-DM phenotype rather than 
neutral polymorph isms in the keratin 14 gene. First, all affected 
individuals in fam ilies EB2 and EB6 were heterozygous for the 
G434A substitution (Fig 1 and 2). None of their unaffected relatives 
had this altera tion. Linkage analysis of these two fami lies provided 
significant evidence for ge netic linkage of keratin 14 and EBS-DM. 
Statisticall y signifi cant evidence in favor of linkage between the 
G434A substitution and the phenotype was obtained with a LaD 
score of3.29 at a recombination fract ion ofO%. Significant evidence 
of linkage (LaD> 3.0) was obtained even when LaD scores were 
calcul ated with a higher all ele frequency of 0.5 , demonstrating that 
the sign ificance of the results were not inflated due to underestima-
tion of the G434A all ele frequency (Materials and Methods). Second, 
neither the G434A nor the C433T alteration was observed upon 
direct sequencing of the exon 1 PCR product from 20 unrelated 
unaffected indi viduals (data not shown). These data, when added to 
the 20 contro l ind ivid uals sequenced previously (9), show that 
codon 125 was not altered in the 80 keratin 14 alleles examined. 
Although supportive of a causal ro le for codon 125 substitutions, 
these data are not robust. If G434A or C433T are polymorphi sms, 
the upper 95% con~fidence bound for their frequency is 3.6%. Last , 
and most important, absence of the G434A and C433T substitu-
tions in the clinically unaffected parents of sporadic EBS-DM pa-
tients (fa milies EBll, EB20, EB27) demonstrated unambiguously 
that these are new D NA alterations, not inherited DNA polymor-
phisms. Together, our data provide strong genetic evidence that 
either the G434A or the C 433T substi tutions are responsible for 
EBS-DM in these families. These genetic data augment the func-
tional stud ies that demonstrated disruption of keratin fil ament as-
sembly both ill vivo and ill vitro resultin g from these substitutions (9). 
T he apparent hypermutability that we detected at keratin 14 
codon 125 arginine residue in EBS-DM patients could result from 
either ascertai nment bias or a mutagenic event that targets this 
codon. Bias cou ld result if other keratin 14 sites are equally mutab le 
but the resultin g phenotype is asymptomatic or typical of another 
subtype of epidermolysis bu ll osa simplex [15). Alternatively, th e 
codon 125 CGC sequence may be preferentially mutated by methyl-
ation-ind uced deamination of 5-methylcytosine (mC) , converting 
a mCpG residue to a TpG sequence. C pG dinucleotides are known 
hypermutable sites where either C -+ T transitions, or th e corre-
spond ing G -+ A on the complimentary strand , acco11l1t for about 
one-third of intragenic single nucl eotide mutat ions responsible for 
human inherited disease [16). The notion that the codon 125 argi-
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nine codon is preferentially mutated is supported by the recent 
finding of a C -+ T transition in a CpG dinucleotide of the same 
conserved argi nine codon of keratin lOin patients with bullous 
congential ichthyosiform erythroderma [15). C heng et al [15) dis-
cuss reasons for the apparent high freq uency of mutation at this 
C pG dinucleotide, versus the numerous other C pG sites in these 
keratin genes. We suggest an add itional possibility based on tissue-
specific differential methylation: all CpG sites of the keratin 14 
gene may not be methylated uniformly in the target cel l that is 
mutated during development. Se lective or preferential methylation 
of the CpG sites of codon 125, in gametogenesis or very early 
embryogenesis, could make this site hypermutable in comparison to 
other CpG residues. This hypoth esis could be investi ga ted by 
studying the methylation status of keratin 14 CpG sites in eggs 
and/or sperm. 
The clinical severity of EBS-DM can be great, and prenatal diag-
nosis has been req uested by families at risk. Although survival past 
infa ncy and improvement into adult life is typical, extensive in-
volvement at birth has resulted in neonatal and infant death [17). 
Recently, the first successful prenatal diagnosis of an EBS-DM-
affected fetus was performed by ultrastructural observation of the 
keratin fil ament clumps that are pathognomonic for EBS-DM in 
fetal skin [18). The occurre nce of keratin 14 codon 125 mutation in 
50% of EBS-DM patients (n = 13; this study and [9)) suggests that 
DNA-based prenata l diagnosis would be informative in a significant 
subset of EBS-DM famili es. If a codon 125 defect is present in a 
sporadic case, the possibility of recurrence due to germline mosai-
cism in a parent could be addressed in subsequent pregnancies by 
DNA studies. Prenata l diagnosis based on DNA analysis could em-
ploy the relat ively low-risk procedures of either chorionic villus or 
amniotic fluid sa mpling rather than fetal sk in biopsy. Direct detec-
tion of the mutation in feta l DNA would avoid any potential mis-
diagnosis by fetal skin biopsy due to variability in the timing and 
extent of keratin clumping during fetal development (18) . 
Even though our studies identified mutations in codon 125 of 
keratin 14 in 50% of the EBS-DM cases examined , mutations re-
sponsible for the remaining five cases have yet to be identified . We 
have determined th at none of th ese cases carries the helix termina-
tion-peptide mutation of kerat in 5 reported in one EBS-DM family 
(8) , suggesting that this site is not another mutational hot spot for 
EBS-DM. Together, these data show that th ere are as yet unidenti-
fi ed mutations in domains of either keratin 5 or 14 that are critical 
for fil ament assembly. Alternatively, these EBS-DM cases may have 
mutations in a novel gene(s) that plays a structural or regul atory role 
in fil ament asse mbl y in the basa l keratinocyte . 
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